Atlas Trials

Safety and Efficacy of Anaerobic Cultivated Human Intestinal Microbiome Transplantation in Systemic Sclerosis (ReSScue)

Clinical trial NCT04300426 · COMPLETED

Trial details

NCT number
NCT04300426
Sponsor
Oslo University Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Systemic Sclerosis
Start date
2020-09-24
Primary completion
2022-06-27
Enrollment
75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.